Serum Visfatin as a Novel Marker of Endothelial Dysfunction in Patients With Type 2 Diabetes

International Journal of Contemporary Medical Research [IJCMR]
doi 10.21276/ijcmr.2018.5.8.7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Marwah Infotech

Related search

Association Between Serum Visfatin Levels and Atherosclerotic Plaque in Patients With Type 2 Diabetes

Diabetology and Metabolic Syndrome
Internal MedicineEndocrinologyMetabolismDiabetes
2019English

The Genetic Aspects of Endothelial Dysfunction in Patients With Type 2 Diabetes Mellitus

Medical News of North Caucasus
Medicine
2015English

ENDOTHELIAL DYSFUNCTION IN TYPE 2 DIABETES. Review

Medical Science of Ukraine (MSU)
2019English

Reciprocal Changes of Serum Adispin and Visfatin Levels in Patients With Type 2 Diabetes After an Overnight Fast

Archives of endocrinology and metabolism
EndocrinologyMetabolismDiabetes
2016English

Serum Leptin Concentration in Patients With Type 2 Diabetes

Current Issues in Pharmacy and Medical Sciences
2015English

Endothelial Dysfunction and Intestinal Dysbiosis in Patients With Non-Alcoholic Steatohepatitis and Type 2 Diabetes Mellitus

Ukraïnsʹkij žurnal medicini, bìologìï ta sportu
2020English

Myocardial Dysfunction in Patients With Type 2 Diabetes Mellitus: Role of Endothelial Progenitor Cells and Oxidative Stress

Cardiovascular Diabetology
Internal MedicineCardiologyEndocrinologyCardiovascular MedicineMetabolismDiabetes
2012English

GlycA Is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients With Type 2 Diabetes

Inflammation
AllergyImmunology
2015English

Markers of Endothelial Dysfunction in Men With Type 2 Diabetes and Their Clinical Significance

Medical News of North Caucasus
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy